Author:
Ntambi Jayne-Norah,Kalyesubula Mugagga,Cootway Dylan,Lewis Sarah A.,Phang Yar Xin,Liu Zhaojin,O'Neill Lucas M.,Lefers Lucas,Huff Hailey,Miller Jacqueline Rose,Pegkou Christofi Veronica,Anderson Ethan,Aljohani Ahmed,Mutebi Francis,Dutta Mainak,Patterson Andrew,Ntambi James M.
Reference50 articles.
1. Found in translation—fibrosis in metabolic dysfunction–associated steatohepatitis (MASH);Wang;Sci. Transl. Med.,2023
2. Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication;Loft;Cell Metab.,2021
3. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2018
4. Liver fibrosis, but no other histologic features;Angulo;is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology,2015
5. NASH in lean individuals;Younes;Semin. Liver Dis.,2019